Legal & General Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,860
| Closed | -$2.4K | – | 3423 |
|
|
2025
Q1 | $2.4K | Hold |
3,860
| – | – | ﹤0.01% | 3344 |
|
|
2024
Q4 | $6.45K | Hold |
3,860
| – | – | ﹤0.01% | 3315 |
|
|
2024
Q3 | $7.05K | Sell |
3,860
-22,027
| -85% | -$40.2K | ﹤0.01% | 3330 |
|
|
2024
Q2 | $156K | Buy |
25,887
+8,701
| +51% | +$52.5K | ﹤0.01% | 2697 |
|
|
2024
Q1 | $192K | Buy |
17,186
+14,897
| +651% | +$166K | ﹤0.01% | 2686 |
|
|
2023
Q4 | $34.1K | Buy |
2,289
+684
| +43% | +$10.2K | ﹤0.01% | 2869 |
|
|
2023
Q3 | $7.7K | Sell |
1,605
-576
| -26% | -$2.77K | ﹤0.01% | 3314 |
|
|
2023
Q2 | $16.4K | Sell |
2,181
-1,083
| -33% | -$8.13K | ﹤0.01% | 3195 |
|
|
2023
Q1 | $14.8K | Sell |
3,264
-3,592
| -52% | -$16.2K | ﹤0.01% | 3143 |
|
|
2022
Q4 | $77.3K | Hold |
6,856
| – | – | ﹤0.01% | 2872 |
|
|
2022
Q3 | $65K | Buy |
6,856
+1,547
| +29% | +$14.7K | ﹤0.01% | 2921 |
|
|
2022
Q2 | $43K | Buy |
5,309
+1,534
| +41% | +$12.4K | ﹤0.01% | 3023 |
|
|
2022
Q1 | $64K | Hold |
3,775
| – | – | ﹤0.01% | 2954 |
|
|
2021
Q4 | $81K | Buy |
3,775
+33
| +0.9% | +$708 | ﹤0.01% | 2951 |
|
|
2021
Q3 | $276K | Buy |
3,742
+1,598
| +75% | +$118K | ﹤0.01% | 2583 |
|
|
2021
Q2 | $117K | Buy |
2,144
+39
| +2% | +$2.13K | ﹤0.01% | 2682 |
|
|
2021
Q1 | $155K | Buy |
2,105
+746
| +55% | +$54.9K | ﹤0.01% | 2500 |
|
|
2020
Q4 | $117K | Buy |
1,359
+289
| +27% | +$24.9K | ﹤0.01% | 2541 |
|
|
2020
Q3 | $40K | Buy |
+1,070
| New | +$40K | ﹤0.01% | 2763 |
|